Rhythm Biosciences Says Australian Laboratory Accreditation Body Confirms Colorectal Cancer Test Meets Standard; Shares Rise 8%

MT Newswires Live

03/09

Rhythm Biosciences (ASX:RHY) said the National Association of Testing Authorities confirmed that its ColoSTAT blood-based colorectal cancer test satisfies all applicable technical and quality requirements under the ISO 15189:2022 standard, according to a Monday Australian bourse filing.

The test's validation and intended clinical application were reviewed in accordance with the National Pathology Accreditation Advisory Council requirements. ColoSTAT was formally listed within the accredited scope of Rhythm's laboratory in Parkville, Victoria.

Its shares jumped 8% in recent trading on Monday.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2618930616"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2618930616\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2618930616?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-09 11:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618930616","market":"fut","top_or_hot":-1,"title":"Rhythm Biosciences Says Australian Laboratory Accreditation Body Confirms Colorectal Cancer Test Meets Standard; Shares Rise 8%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/RHYN.AU\">Rhythm Biosciences</a> (ASX:RHY) said the National Association of Testing Authorities confirmed that its ColoSTAT blood-based colorectal cancer test satisfies all applicable technical and quality requirements under the ISO 15189:2022 standard, according to a Monday Australian bourse filing.</p><p>The test's validation and intended clinical application were reviewed in accordance with the National Pathology Accreditation Advisory Council requirements. ColoSTAT was formally listed within the accredited scope of Rhythm's laboratory in Parkville, <a href=\"https://laohu8.com/S/VCCTF\">Victoria</a>.</p><p>Its shares jumped 8% in recent trading on Monday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rhythm Biosciences Says Australian Laboratory Accreditation Body Confirms Colorectal Cancer Test Meets Standard; Shares Rise 8%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRhythm Biosciences Says Australian Laboratory Accreditation Body Confirms Colorectal Cancer Test Meets Standard; Shares Rise 8%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-03-09 11:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/RHYN.AU\">Rhythm Biosciences</a> (ASX:RHY) said the National Association of Testing Authorities confirmed that its ColoSTAT blood-based colorectal cancer test satisfies all applicable technical and quality requirements under the ISO 15189:2022 standard, according to a Monday Australian bourse filing.</p><p>The test's validation and intended clinical application were reviewed in accordance with the National Pathology Accreditation Advisory Council requirements. ColoSTAT was formally listed within the accredited scope of Rhythm's laboratory in Parkville, <a href=\"https://laohu8.com/S/VCCTF\">Victoria</a>.</p><p>Its shares jumped 8% in recent trading on Monday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XKO.AU","symbol_name":"标普/澳交所 300指数","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2618930616","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618930616","pubTimestamp":1773026565,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Rhythm Biosciences  said the National Association of Testing Authorities confirmed that its ColoSTAT blood-based colorectal cancer test satisfies all applicable technical and quality requirements under the ISO 15189:2022 standard, according to a Monday Australian bourse filing.The test's validation and intended clinical application were reviewed in accordance with the National Pathology Accreditation Advisory Council requirements. ColoSTAT was formally listed within the accredited scope of Rhythm's laboratory in Parkville, Victoria.Its shares jumped 8% in recent trading on Monday.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XKO.AU":"标普/澳交所 300指数","BK4124":"机动车零配件与设备","BK7124":"保健护理服务","SMP":"Standard Motor Products Inc","XAO.AU":"标普/澳交所 普通股指数","XJO.AU":"标普/澳交所 200指数","RHY.AU":"RHYTHM BIOSCIENCES LTD"},"translate_title":"Rhythm Biosciences表示澳大利亚实验室认证机构确认结直肠癌检测符合标准；股价上涨8%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XAO.AU":1.5,"XKO.AU":1.5,"SMP":1.5,"XJO.AU":1.5,"RHY.AU":1},"content_text":"Rhythm Biosciences (ASX:RHY) said the National Association of Testing Authorities confirmed that its ColoSTAT blood-based colorectal cancer test satisfies all applicable technical and quality requirements under the ISO 15189:2022 standard, according to a Monday Australian bourse filing.The test's validation and intended clinical application were reviewed in accordance with the National Pathology Accreditation Advisory Council requirements. ColoSTAT was formally listed within the accredited scope of Rhythm's laboratory in Parkville, Victoria.Its shares jumped 8% in recent trading on Monday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}